Robert Shawah | executive |
David Luci | executive |
Jason Mccarthy | analyst |
Wing Yip | analyst |
James Molloy | analyst |
Greetings. Welcome to the Acurx Pharmaceuticals Second Quarter 2024 Financial Results. [Operator Instructions] Please note that this conference is being recorded. At this time, I'll now turn the conference over to Rob Shawah, Chief Financial Officer. Rob, you may begin.